His work focuses on biochemical, physiological and nutritional research. This represents the research in nutrition sciences area has significant clinic implications in providing innovative and improved treatments for a variety of nutrition-related diseases such as obesity, diabetes, Short Bowel Syndrome (SBS) and Phenylketonuria (PKU). He has 22 publications, 9 presentations with 50 citations.

She has a PhD in Biochemistry from BU. Her work focuses on cancer and cardiovascular disease research- DNA repair enzymes and pathways in bacteria and human systems. She has 19 publications with 187 citations. Reviewed 33 papers for 20 journals.

He has a PhD in Biochemistry and Molecular Biology from Chinese Academy of Sciences. He has 10 journal publications, 6 conference presentations, and 1 book chapter with 70 citations. 2 media reports.

He has 10 publications, 6 conference presentations with 55 citations. No review. He claimed critical role in the company. He has a PhD in biochemistry and biophysics with a concentration on bioavailability of nutrients from Iowa State University. His H1B reached 6 years at the time of filing O1.

The company conducts R&D on medical device. She has a Ph.D in Bioengineering from University of Washington. She has 14 publications, 2 patents with around 70 citations; reviewed 24 manuscripts. Her work at the company focuses on acoustic engineering-medical therapeutic ultrasound.